Progyny Share Price (NASDAQ: PGNY)

$23.66

▲

0.41

(1.76%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Progyny Stock chart to analyse performance

Progyny stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$23.30
Today's High:$23.81
$23.66
1.52%
Downside
Day's Volatility :2.14%
Upside
0.63%
52 Weeks Low:$13.39
52 Weeks High:$26.76
$23.66
43.41%
Downside
52 Weeks Volatility :49.96%
Upside
11.58%

Progyny Stock Returns

Period	Progyny Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	9.01%	3.6%	0.0%
6 Months	7.52%	-7.7%	0.0%
1 Year	0.28%	-12.6%	0.0%
3 Years	-39.35%	10.2%	-4.1%

Progyny Inc Key Stats

Check Progyny key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$23.25
Open	$23.31
Today's High	$23.81
Today's Low	$23.3
Market Capitalization	$2.0B
Today's Volume	$1.1M
52 Week High	$26.76
52 Week Low	$13.39
Revenue TTM	$1.2B
EBITDA	$80.8M
Earnings Per Share (EPS)	$0.59
PE Ratio	39.41
Profit Margin	4.28%
Quarterly Earnings Growth YOY	0.12%
Return On Equity TTM	10.94%

Stock Returns calculator for Progyny Stock including INR - Dollar returns

The Progyny stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Progyny investment value today

Current value as on today

₹1,05,581

Returns

₹5,581

(+5.58%)

Returns from Progyny Stock

₹297 (+0.30%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Progyny Stock

94%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Progyny Stock from India on INDmoney has increased by 94% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Progyny Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
14.85%
Vanguard Group Inc
11.48%
FMR Inc
4.78%
Thrivent Financial For Lutherans
3.95%
State Street Corp
3.39%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
2.20%

Analyst Recommendation on Progyny Stock

Rating

Trend

Buy

93%Buy

6%Hold

0%Sell

Based on 16 Wall street analysts offering stock ratings for Progyny(by analysts ranked 0 to 5 stars)

Progyny Share Price Target

What analysts predicted

Upside of 19.4%

Target:

$28.25

Current:

$23.66

Progyny share price target is $28.25, a slight Upside of 19.4% compared to current price of $23.66 as per analysts' prediction.

Progyny Stock Insights

Price Movement
In the last 3 years, PGNY stock has moved down by -41.2%
Increasing Revenue
Revenue is up for the last 4 quarters, 286.62M → 332.87M (in $), with an average increase of 4.8% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, 10.42M → 17.11M (in $), with an average increase of 14.4% per quarter
PGNY vs CVS (1 yr)
In the last 1 year, Cvs Health Corporation has given 27.8% return, outperforming this stock by 27.1%
PGNY vs CI (3 yr)
In the last 3 years, Progyny Inc has experienced a drawdown of -41.2%, however The Cigna Corp resisted the overall trend and outperformed by 15.8%
Price to Sales
ForPGNY every $1 of sales, investors are willing to pay $1.7, whereas for Cvs Health Corporation, the investors are paying $0.2 for every $1 of sales.

Progyny Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$229.7M	↑ 117.92%
Net Income	$-8.6M	↓ 1396.37%
Net Profit Margin	-3.73%	↓ 4.36%

	FY20	Y/Y Change
Revenue	$344.9M	↑ 50.15%
Net Income	$46.5M	↓ 642.18%
Net Profit Margin	13.47%	↑ 17.2%

	FY21	Y/Y Change
Revenue	$500.6M	↑ 45.17%
Net Income	$65.8M	↑ 41.56%
Net Profit Margin	13.14%	↓ 0.33%

	FY22	Y/Y Change
Revenue	$786.9M	↑ 57.19%
Net Income	$30.4M	↓ 53.84%
Net Profit Margin	3.86%	↓ 9.28%

	FY23	Y/Y Change
Revenue	$1.1B	↑ 38.34%
Net Income	$62.0M	↑ 104.35%
Net Profit Margin	5.7%	↑ 1.84%

	FY24	Y/Y Change
Revenue	$1.2B	↑ 7.22%
Net Income	$54.3M	↓ 12.41%
Net Profit Margin	4.66%	↓ 1.04%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$278.1M	↑ 3.01%
Net Income	$16.9M	↑ 25.45%
Net Profit Margin	6.08%	↑ 1.09%

	Q2 FY24	Q/Q Change
Revenue	$304.1M	↑ 9.35%
Net Income	$16.5M	↓ 2.44%
Net Profit Margin	5.42%	↓ 0.66%

	Q3 FY24	Q/Q Change
Revenue	$286.6M	↓ 5.74%
Net Income	$10.4M	↓ 36.78%
Net Profit Margin	3.64%	↓ 1.78%

	Q4 FY24	Q/Q Change
Revenue	$298.4M	↑ 4.12%
Net Income	$10.5M	↑ 1.07%
Net Profit Margin	3.53%	↓ 0.11%

	Q1 FY25	Q/Q Change
Revenue	$324.0M	↑ 8.58%
Net Income	$15.1M	↑ 42.98%
Net Profit Margin	4.65%	↑ 1.12%

	Q2 FY25	Q/Q Change
Revenue	$332.9M	↑ 2.73%
Net Income	$17.1M	↑ 13.63%
Net Profit Margin	5.14%	↑ 0.49%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$45.5M	↑ 134.15%

	FY20	Y/Y Change
Profit	$70.1M	↑ 53.96%

	FY21	Y/Y Change
Profit	$112.1M	↑ 60.06%

	FY22	Y/Y Change
Profit	$167.3M	↑ 49.22%

	FY23	Y/Y Change
Profit	$238.8M	↑ 42.72%

	FY24	Y/Y Change
Profit	$253.4M	↑ 6.1%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$62.4M	↑ 9.69%

	Q2 FY24	Q/Q Change
Profit	$68.3M	↑ 9.41%

	Q3 FY24	Q/Q Change
Profit	$59.2M	↓ 13.24%

	Q4 FY24	Q/Q Change
Profit	$63.4M	↑ 7.07%

	Q1 FY25	Q/Q Change
Profit	$75.8M	↑ 19.49%

	Q2 FY25	Q/Q Change
Profit	$79.0M	↑ 4.19%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-1.5M	↓ 167.52%
Investing Cash Flow	$-2.8M	↓ 244.9%
Financing Cash Flow	$84.5M	↓ 1067.56%

	FY20	Y/Y Change
Operating Cash Flow	$36.2M	↓ 2460.04%
Investing Cash Flow	$-40.0M	↑ 1352.5%
Financing Cash Flow	$-6.2M	↓ 107.39%

	FY21	Y/Y Change
Operating Cash Flow	$26.0M	↓ 28.08%
Investing Cash Flow	$8.8M	↓ 121.9%
Financing Cash Flow	$-13.7M	↑ 119.16%

	FY22	Y/Y Change
Operating Cash Flow	$80.4M	↑ 208.77%
Investing Cash Flow	$-43.9M	↓ 600.41%
Financing Cash Flow	$-7.9M	↓ 42.58%

	FY23	Y/Y Change
Operating Cash Flow	$188.8M	↑ 134.86%
Investing Cash Flow	$-200.5M	↑ 357.13%
Financing Cash Flow	$-11.1M	↑ 40.79%

	FY24	Y/Y Change
Operating Cash Flow	$179.1M	↓ 5.14%
Investing Cash Flow	$195.8M	↓ 197.64%
Financing Cash Flow	$-309.9M	↑ 2698.77%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$25.7M	↓ 31.67%
Investing Cash Flow	$19.3M	↓ 120.71%
Financing Cash Flow	$-27.4M	↑ 445.49%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$56.7M	↑ 120.32%
Investing Cash Flow	$86.1M	↑ 345.08%
Financing Cash Flow	$-162.8M	↑ 493.88%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$44.5M	↓ 21.48%
Investing Cash Flow	$15.4M	↓ 82.16%
Financing Cash Flow	$-63.4M	↓ 61.08%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$52.2M	↑ 17.18%
Investing Cash Flow	$75.0M	↑ 388.15%
Financing Cash Flow	$-56.3M	↓ 11.09%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$49.8M	↓ 4.52%
Investing Cash Flow	$-94.6M	↓ 226.16%
Financing Cash Flow	$-3.3M	↓ 94.16%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$55.5M	↑ 11.45%
Investing Cash Flow	$-29.9M	↓ 68.38%
Financing Cash Flow	$-2.3M	↓ 29.17%

Progyny Technicals Summary

Sell

Neutral

Buy

Progyny is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Progyny Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Progyny Inc	5.18%	7.52%	0.28%	-39.35%	-63.23%
The Cigna Corp	14.77%	-3.39%	-17.65%	4.49%	70.85%
Cvs Health Corporation	17.84%	12.76%	27.54%	-26.77%	21.4%
Humana Inc.	22.81%	16.11%	-16.47%	-37.64%	-26.8%
Elevance Health, Inc	16.03%	-19.42%	-43.32%	-34.99%	16.7%
Unitedhealth Group Incorporated	30.33%	-33.65%	-48.24%	-40.86%	-0.94%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Progyny Inc	39.41	39.41	NA	1.74	0.11	0.07	NA	6.04
The Cigna Corp	16.39	16.39	0.59	29.66	0.13	0.04	0.02	150.84
Cvs Health Corporation	20.09	20.09	0.75	6.31	0.06	0.02	0.04	61.07
Humana Inc.	23.25	23.25	1.01	16.93	0.09	0.05	0.01	151.61
Elevance Health, Inc	13.18	13.18	0.84	30.02	0.12	0.05	0.02	194.46
Unitedhealth Group Incorporated	13.09	13.09	1.24	16.22	0.22	0.06	0.03	104.67

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Progyny Inc	Buy	$2.0B	-63.23%	39.41	4.28%
The Cigna Corp	Buy	$80.1B	70.85%	16.39	1.92%
Cvs Health Corporation	Buy	$91.5B	21.4%	20.09	1.18%
Humana Inc.	Buy	$36.5B	-26.8%	23.25	1.28%
Elevance Health, Inc	Buy	$69.9B	16.7%	13.18	2.83%
Unitedhealth Group Incorporated	Buy	$273.8B	-0.94%	13.09	5.04%

About Progyny Inc

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Organization	Progyny
Employees	675
CEO	Mr. Peter Anevski CPA
Industry	Commercial Services

Key Management of Progyny Inc

Name	Title
Mr. David J. Schlanger J.D.	Executive Chairman
Mr. Peter Anevski CPA	CEO & Director
Mr. Michael Sturmer	President
Ms. Allison Swartz	Executive VP, General Counsel & Secretary
Ms. Melissa B. Cummings	Chief Operating Officer
Mr. Steven Leist	Chief Technology Officer
Mr. James Hart	Vice President of Investor Relations
Ms. Risa Fisher	Chief Marketing Officer
Ms. Cassandra Pratt	Chief Human Resources Officer
Ms. Julie Stadlbauer	Chief Business Development Officer

Important FAQs about investing in PGNY Stock from India :

What is Progyny share price today?

Progyny share price today is $23.66 as on August 30, 2025 at 1:29 am IST at the close of the market. Progyny share today touched a day high of $23.81 and a low of $23.30.

What is the 52 week high and 52 week low for Progyny share?

Progyny share touched a 52 week high of $26.76 and a 52 week low of $13.39. Progyny stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $23.66, lower by 11.58% versus the 52 week high.

How to invest in Progyny Stock (PGNY) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Progyny on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Progyny Shares that will get you 0.0634 shares as per Progyny share price of $23.66 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Progyny Stock (PGNY) from India?

Indian investors can start investing in Progyny (PGNY) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Progyny stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Progyny share’s latest price of $23.66 as on August 30, 2025 at 1:29 am IST, you will get 0.4227 shares of Progyny. Learn more about fractional shares .

What are the returns that Progyny has given to Indian investors in the last 5 years?

Progyny stock has given -63.23% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?